InsidersTradesSigma
ST人福 Stock: price and directors' dealings · China · SSE / SZSE (CSRC)
Track the ST人福 share price and the full insider trade history of the company, a listed equity based in China. Shares are listed on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST人福 has published 20 reports. Market capitalisation: €29.6bn. The latest transaction was filed on 11 September 2024 (Sale). Among the most active insiders: 徐华斌. Every trade is free.
20
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
€11m
19 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 5,133 of 25,484 companies
66.8
score / 100
Value71
Quality62
FCF yld6.3%
Earn yld6.6%
EV/EBITDA8.5x
ROE12%
Gross mgn48%
Net mgn7.7%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 September 2024
Declarations20 total
20 of 20 declarations